Protective effect of liraglutide against ER stress in the liver of high-fat diet-induced insulin-resistant rats. (Q51311480)

3 April 2018

title

Protective effect of liraglutide against ER stress in the liver of high-fat diet-induced insulin-resistant rats. (English)

1 reference

3 April 2018

1 reference

1 reference

Jing Yang

1

1 reference

3 April 2018

Na Ao

2

1 reference

3 April 2018

Jian Du

3

1 reference

3 April 2018

Xiaochen Wang

4

1 reference

3 April 2018

Yini He

5

1 reference

3 April 2018

publication date

25 November 2014

1 reference

3 April 2018

published in

Endocrine

1 reference

3 April 2018

volume

49

1 reference

3 April 2018

issue

1

1 reference

3 April 2018

page(s)

106-118

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s12020-014-0480-y

exact match

0 references

cites work

Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Therapeutic strategies based on glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Liraglutide for the treatment of type 2 diabetes: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Liraglutide: the therapeutic promise from animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Endoplasmic reticulum stress in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Effect of Liraglutide on endoplasmic reticulum stress in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

KLF15 is a molecular link between endoplasmic reticulum stress and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Retracted: Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B Axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Relationship between tyrosine phosphorylation and protein expression of insulin receptor and insulin resistance in gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Involvement of endoplasmic reticulum stress in apoptosis of testicular cells induced by low-dose radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Towards an integrative approach to understanding the role of chemerin in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Molecular cloning and tissue distribution of cDNA encoding a novel chemoattractant-like receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Downregulation of chemerin and alleviation of endoplasmic reticulum stress by metformin in adipose tissue of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Pioglitazone acutely reduces energy metabolism and insulin secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Emerging role of JNK in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

(-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Plasma chemerin level in metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0480-Y

Wen-pi-tang-Hab-Wu-ling-san, a Polyherbal Medicine, Attenuates ER Stress in 3T3-L1 Preadipocytes by Promoting the Insulin Signaling Pathway

21 January 2018

1 reference

12 December 2020

Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway

1 reference

12 December 2020

Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP-triggered apoptosis via the inhibition of the IRE-α pathway.

1 reference

12 December 2020

1 reference

12 December 2020

Incorporating glucagon-like peptide-1 receptor agonists into clinical practice.

1 reference

12 December 2020

10.1007/S12020-014-0480-Y

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

25471281

1 reference

3 April 2018